Cynata Therapeutics Ltd V.CYP

Primary Symbol: CYYNF

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.

OTCPK:CYYNF - Post by User

Cynata Therapeutics Ltd

Bullboard Posts

Comment by GarryJan1on Jul 29, 2019 7:49pm

98 Views

Post# 29972793

RE:Average Down?

I have a few bids in.

The lithium market has slowed down and we are near the turning point where the new battery companies ramp up production and using up any excess lithium.

The USA is now under Trump who wants home made lithium as well as many other crucial minerals. So it might just surprize us one day that a large entity has decided to take a bite out of us.

I bought a few more the other day at 17.5 as I believe we are still lucky to get the shares cheep, when we do eventually get above the 50s there will be no turning back imho.

Ps: Even if its a dissappointment to the existing holders, if the PP is over subscribbed it will show how much interest the $$ people are in the project and bode well for future investments.

Bullboard Posts

Is China getting serious? Rheinmetall and Almonty Industries profit